Pt Care: Urologic Oncology: Our Team

Our Team

Division Chief

  • Sam S. Chang, MD, MBA

    Professor
    Department of Urology
    Patricia and Rodes Hart Professor of Urologic Surgery
    Chief Surgical Officer
    Vanderbilt Ingram Cancer Center
    Chief
    Division of Urologic Oncology

    Medical School: Vanderbilt University School of Medicine
    Residency: Vanderbilt University Medical Center
    Fellowship: Memorial Sloan-Kettering Cancer Center
    Clinical Interests: Prostate cancer, Prostatectomy, Bladder cancer, Kidney cancer, Urologic cancer

    Dr. Chang, the Chief Surgical Officer at the Vanderbilt Ingram Cancer Center, formerly chaired the American Joint Committee on GU Cancer Staging Task Force and currently is the Assistant Secretary of the American Urological Association and Chair of the American Board of Urology Examination Committee responsible for board certification in the U.S

  • Daniel A. Barocas, MD, MPH, FACS

    Professor
    Department of Urology
    Executive Vice Chair
    Department of Urology
    Division of Urologic Oncology

    Medical School: Johns Hopkins University School of Medicine
    Residency: New York Presbyterian Hospital-Weill Cornell Medical Center
    Fellowship: Vanderbilt University Medical Center
    Clinical Interests: Genitourinary Cancer, Prostate Cancer, Kidney Cancer, Bladder Cancer, Laparoscopy and Robotics

    Dr. Barocas is an accomplished researcher, focusing on quality of life, quality of care, healthcare disparities and comparative effectiveness. He is the principal investigator of a multi-center study on the effectiveness and side effects of different treatments for prostate cancer.

  • Meredith E. Donahue, APRN-BC

    Nurse Practitioner
    Department of Urology
    Division of Urologic Oncology

    Undergrad: Furman University
    Nursing School: Vanderbilt University School of Nursing
    Fellowship: Vanderbilt Urology NP Fellowship
    Clinical Interests: Prostate Cancer, Bladder Cancer, Kidney Cancer, Genitourinary Cancer, Testis Cancer

  • Amy N. Luckenbaugh, MD

    Assistant Professor
    Department of Urology
    Division of Urologic Oncology

    Medical Degree: State University of New York at Buffalo
    Residency: University of Michigan
    Fellowship: Vanderbilt University Medical Center
    Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer

    Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as a member of the Society of Women in Urology board, and through her research aims to mitigate variation in healthcare delivery.
     

  • Kelvin Moses, MD, PhD

    Associate Professor
    Department of Urology
    Fellowship Director
    Urologic Oncology Fellowship
    Division of Urologic Oncology

    Medical School: Baylor College of Medicine, Houston, TX
    Residency: Emory University School of Medicine, Atlanta, GA
    Fellowship: Memorial Sloan-Kettering Cancer Center, New York, NY
    Clinical Interests: Advanced Prostate Cancer, Advanced Kidney Cancer, Testis Cancer, Penile Cancer, Adrenal Cancer

    Dr. Moses is the Director of the Comprehensive Prostate Cancer clinic and has research interests in health literacy and cancer outcomes, advanced prostate cancer clinical trials, and health disparities in Urologic cancers.

  • Wendy Nichols, DNP, APRN, FNP-C

    Nurse Practitioner
    Department of Urology
    Division of Urologic Oncology

    Undergrad: Roberts Wesleyan College
    Nursing School: University of Rochester
    Doctorate NP: Grand Canyon University
    Clinical Interests: Benign Prostatic Hyperlasia, Elevated PSA, Female Urology, Male Urology/Men's Health, Urologic Cancer

  • Maggie O'Block, WHNP-BC, AGPCNP-BC

    Nurse Practitioner
    Department of Urology
    Division of Urologic Oncology

    Undergrad: Santa Clara University
    Nursing School: Vanderbilt University School of Nursing
    Clinical Interests: Genitourinary Cancer, Prostate Cancer, Bladder Cancer, Testis Cancer, Kidney Cancer

  • David F. Penson, MD, MPH, MMHC

    Professor and Chair
    Department of Urology
    Hamilton and Howd Chair in Urologic Oncology
    Division of Urologic Oncology

    Medical School: Boston University School of Medicine
    Residency: University of California, Los Angeles
    Fellowship: Robert Wood Johnson Clinical Scholars Program
    Clinical Interests: Prostate cancer, Bladder cancer, Prostatectomy, Elevated PSA

    Dr Penson serves as Chair of the Department and oversees all Departmental activities. He is also a well-known health services researcher, a urologic oncologist who focuses on clinical prostate and bladder cancer care and, most importantly, the father of three great kids (all of whom are die-hard Boston Red Sox fans, like their dad).

  • Joseph A. Smith, Jr, MD

    Professor
    Department of Urology
    William L. Bray Professor
    Division of Urologic Oncology

    Medical School: University of Tennessee School of Medicine
    Residency: University of Texas Southwestern Medical School/University of Utah
    Fellowship: Memorial Sloan-Kettering Cancer Center
    Clinical Interests: Bladder cancer, Prostate cancer, Prostatectomy, Urologic Cancer, Genitourinary Cancer

    Dr Smith has focused his career on innovative treatments and surgical procedures for urologic cancer.  He is one of the most experienced surgeons in the world and has performed over 10,000 robotic prostatectomies for prostate cancer and more than 1,000 cystectomies for bladder cancer.

  • Kristen R. Scarpato, MD, MPH

    Associate Professor
    Department of Urology
    Residency Program Director
    Department of Urology
    Vice Chair of Education
    Department of Urology
    Division of Urologic Oncology

    Medical Degree: Tufts University School of Medicine
    Residency: University of Connecticut Health Center
    Fellowship: Vanderbilt University Medical Center
    Clinical Interests: Bladder Cancer, Genitourinary Cancer, Prostate Cancer, Prostatectomy, Ultrasound Fusion Biopsy/Artemis
     

    Dr. Scarpato currently serves as the Program Director for the urology residency program.  She has particular interests in resident and medical student education, surgical simulation, and mentorship.  She is currently enrolled in Vanderbilt’s Educational Scholars Development 2020 – 2022 Program and looking forward to completing the AUA Leadership Program 2021- 2022.  She enjoys riding her bike and adventuring with her husband and two children.  

  • Cary (CJ) Stimson, MD, JD

    Assistant Professor
    Department of Urology
    Senior Vice President of Value Transformation
    Office of Population Health
    Chief Medical Officer
    VUMC and Vanderbilt University Employee Health Plan
    Division of Urologic Oncology

    Medical School: Vanderbilt University School of Medicine, Nashville, TN
    Residency: Vanderbilt University Medical Center, Nashville, TN
    Fellowship: Johns Hopkins Hospital, Baltimore, MD

  • Jeffrey Tosoian, MD, MPH

    Assistant Professor
    Department of Urology
    Division of Urologic Oncology

    Medical School: Johns Hopkins University
    Residency: Johns Hopkins Hospital
    Fellowship: University of Michigan
    Clinical Interests: Prostate Cancer, Elevated PSA, Kidney Cancer, Bladder Cancer, Testis Cancer

    Dr. Tosoian specializes in the surgical and non-surgical management of urologic cancers. His research is focused on the clinical application of new and existing tools (e.g. blood-, urine-, and tissue-based markers) to improve the detection and management of urologic cancers.